Panag Pharma Completes Phase 3 Trial With Awaye™

    NEXT STORY
    G1 Therapeutics to Present at Raymond James Life Sciences and MedTech Conference
    PREV STORY
    ELSAH-PROJEKT SETZT NEUE MASSSTÄBE BEI WEARABLES
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute

    WALTHAM, Mass., July 02, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    2020 Annual Eric Dostie Memorial College Scholarship Winners

    author_avatar
    NASDAQ Market News

    Zentalis Pharmaceuticals Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    author_avatar
    NASDAQ Market News